Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Mircera

02 1NeoRecormon

03 4NeoRecormon/Epogin

04 2Neorecormon/Epogin

PharmaCompass

01

arrow
Biotech Showcase
Not Confirmed

02

Brand Name : NeoRecormon/Epogin

Methoxy Polyethylene Glycol-Epoetin Beta

arrow
Biotech Showcase
Not Confirmed

03

Brand Name : NeoRecormon/Epogin

Methoxy Polyethylene Glycol-Epoetin Beta

arrow
Biotech Showcase
Not Confirmed

04

arrow
Biotech Showcase
Not Confirmed

05

arrow
Biotech Showcase
Not Confirmed

06

arrow
Biotech Showcase
Not Confirmed

07

arrow
Biotech Showcase
Not Confirmed

08

Brand Name : NeoRecormon

Epoetin Beta, Epoetin Alfa

arrow
Biotech Showcase
Not Confirmed

Brand Name : NeoRecormon

arrow
Biotech Showcase
Not Confirmed

Epoetin Beta, Epoetin Alfa

Main Therapeutic Indication : Blood Related Disorders

Currency : USD

2014 Revenue in Millions : -11.50%

2013 Revenue in Millions :

Growth (%) :

blank

09

Brand Name : NeoRecormon/Epogin

Epoetin Beta, Epoetin Alfa

arrow
Biotech Showcase
Not Confirmed

Brand Name : NeoRecormon/Epogin

arrow
Biotech Showcase
Not Confirmed

Epoetin Beta, Epoetin Alfa

Main Therapeutic Indication : Blood Related Disorders

Currency : USD

2015 Revenue in Millions : 465

2014 Revenue in Millions : 370

Growth (%) : -20%

blank

10

Brand Name : Neorecormon/Epogin

Epoetin Beta, Epoetin Alfa

arrow
Biotech Showcase
Not Confirmed

Brand Name : Neorecormon/Epogin

arrow
Biotech Showcase
Not Confirmed

Epoetin Beta, Epoetin Alfa

Main Therapeutic Indication : Blood Disorders

Currency : USD

2016 Revenue in Millions : 325

2015 Revenue in Millions : 362

Growth (%) : -10

blank